Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Infectious Disease Reports|August 28, 2024
Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief OverviewMaria Letizia Giancola, Andrea Angheben, Laura Scorzolini, et al.Eclinicalmedicine|May 18, 2022
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19Emanuele Nicastri, Franco Marinangeli, Emanuele Pivetta, et al.Infectious Diseases of Poverty|January 12, 2026
Tuberculous mastitis, the great imitator in breast disease: a case report with diagnostic and therapeutic challengesSerena Vita, Claudia Piccolo, Gaetano Maffongelli, et al.Open Forum Infectious Diseases|February 2, 2021
Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response KineticsFrancesca Colavita, Daniele Lapa, Fabrizio Carletti, et al.The Journal of Infection|February 20, 2026
The DENGVAC Study: Preliminary Findings on the Immunogenicity of the TAK-003 Dengue VaccineAlessandra D'Abramo, Francesca Colavita, Laura Ponzetta, et al.Cell Death & Disease|May 25, 2022
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variantsDaniela Iaconis, Licia Bordi, Giulia Matusali, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2023
Lymphofollicular lesions associated with monkeypox (Mpox) virus proctitisValentina Mazzotta, Laura Scorzolini, Laura Falasca, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 27, 2020
Coronavirus disease (COVID-19) in a paucisymptomatic patient: epidemiological and clinical challenge in settings with limited community transmission, Italy, February 2020Emanuele Nicastri, Alessandra D'Abramo, Giovanni Faggioni, et al.Science Translational Medicine|October 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adultsSimone Lanini, Stefania Capone, Andrea Antinori, et al.Cell Reports. Medicine|April 27, 2022
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failureEvangelos J Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, et al.Pageof 4